Syra Health Corp
SYRA· OTC
SYRASyra Health Corp
Filed Nov 14, 2023 · 10-Q · 45 days after period end · 0001493152-23-040869
| Metric | Q3 2023 | Q3 2022 |
|---|---|---|
| Revenue | $1.58M | $1.51M |
| Net Income | -$354.38K | -$354.54K |
| EPS Diluted | -$0.08 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Syra Health Corp · CIK 1922335 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 14, 2023 · 45 d after period end
